In multiple regression analyses, SCT significantly predicted lower cEPC number after adjusting for age, BMI, BP, CVRs (smoking status, IHD, diabetes, use of aspirin/angiotensin-converting enzyme inhibitor/angiotensin receptor blocker intake, total cholesterol (TC), high-density lipoprotein (HDL-C), low-density lipoprotein (LDL-C), standardized β coefficient/p-value), CD34+ (−0.68/0.001), CD133+ (−0.51/0.016), CD133+/VEGFR-2+ (−0.59/0.006), CD34+/VEGFR-2+ (−0.58/0.012), CD144+/CD34+ (−0.618/0.001), and CD144+/CD133+ (−0.617/0.001). This evidence concerns the gene ACE and myocardial ischemia.